These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 33019813)

  • 1. Effects of Brief Adjunctive Metformin Therapy in Virologically Suppressed HIV-Infected Adults on Polyfunctional HIV-Specific CD8 T Cell Responses to PD-L1 Blockade.
    Chew GM; Padua AJP; Chow DC; Souza SA; Clements DM; Corley MJ; Pang APS; Alejandria MM; Gerschenson M; Shikuma CM; Ndhlovu LC
    AIDS Res Hum Retroviruses; 2021 Jan; 37(1):24-33. PubMed ID: 33019813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in gastrointestinal microbial communities influence HIV-specific CD8+ T-cell responsiveness to immune checkpoint blockade.
    SahBandar IN; Chew GM; Corley MJ; Pang APS; Tsai N; Hanks N; Khadka VS; Klatt NR; Hensley-McBain T; Somsouk M; Vujkovic-Cvijin I; Chow DC; Shikuma CM; Ndhlovu LC
    AIDS; 2020 Aug; 34(10):1451-1460. PubMed ID: 32675558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Programmed death (PD)-1 molecule and its ligand PD-L1 distribution among memory CD4 and CD8 T cell subsets in human immunodeficiency virus-1-infected individuals.
    Rosignoli G; Lim CH; Bower M; Gotch F; Imami N
    Clin Exp Immunol; 2009 Jul; 157(1):90-7. PubMed ID: 19659774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short Communication: Metformin Reduces CD4 T Cell Exhaustion in HIV-Infected Adults on Suppressive Antiretroviral Therapy.
    Shikuma CM; Chew GM; Kohorn L; Souza SA; Chow D; SahBandar IN; Park EY; Hanks N; Gangcuangco LMA; Gerschenson M; Ndhlovu LC
    AIDS Res Hum Retroviruses; 2020 Apr; 36(4):303-305. PubMed ID: 31731885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed Expression of PD-1 and TIGIT on HIV-Specific CD8 T Cells in Untreated HLA-B*57:01 Individuals Followed from Early Infection.
    Scharf L; Tauriainen J; Buggert M; Hartogensis W; Nolan DJ; Deeks SG; Salemi M; Hecht FM; Karlsson AC
    J Virol; 2020 Jul; 94(14):. PubMed ID: 32350076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin reduces PD-L1 on tumor cells and enhances the anti-tumor immune response generated by vaccine immunotherapy.
    Munoz LE; Huang L; Bommireddy R; Sharma R; Monterroza L; Guin RN; Samaranayake SG; Pack CD; Ramachandiran S; Reddy SJC; Shanmugam M; Selvaraj P
    J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34815353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of Gag- and Env-Specific CD8+ T Cell Responses in ART-Naïve HIV-Infected Patients: Potential Implications for Individualized Immunotherapy.
    Prebensen C; Lind A; Dyrhol-Riise AM; Kvale D
    PLoS One; 2016; 11(4):e0153849. PubMed ID: 27128502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PD-1/PD-L1 blockade can enhance HIV-1 Gag-specific T cell immunity elicited by dendritic cell-directed lentiviral vaccines.
    Dai B; Xiao L; Bryson PD; Fang J; Wang P
    Mol Ther; 2012 Sep; 20(9):1800-9. PubMed ID: 22588271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of PD-L1 inhibition effects for HIV-infected individuals.
    Zheltkova V; Argilaguet J; Peligero C; Bocharov G; Meyerhans A
    PLoS Comput Biol; 2019 Nov; 15(11):e1007401. PubMed ID: 31693657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of the CD8
    Li J; Huang HH; Tu B; Zhou MJ; Hu W; Fu YL; Li XY; Yang T; Song JW; Fan X; Jiao YM; Xu RN; Zhang JY; Zhou CB; Yuan JH; Zhen C; Shi M; Wang FS; Zhang C
    Front Immunol; 2021; 12():687296. PubMed ID: 34177939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Trial of the Anti-PD-L1 Antibody BMS-936559 in HIV-1 Infected Participants on Suppressive Antiretroviral Therapy.
    Gay CL; Bosch RJ; Ritz J; Hataye JM; Aga E; Tressler RL; Mason SW; Hwang CK; Grasela DM; Ray N; Cyktor JC; Coffin JM; Acosta EP; Koup RA; Mellors JW; Eron JJ;
    J Infect Dis; 2017 Jun; 215(11):1725-1733. PubMed ID: 28431010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. siRNA knockdown of PD-L1 and PD-L2 in monocyte-derived dendritic cells only modestly improves proliferative responses to Gag by CD8(+) T cells from HIV-1-infected individuals.
    Breton G; Yassine-Diab B; Cohn L; Boulassel MR; Routy JP; Sékaly RP; Steinman RM
    J Clin Immunol; 2009 Sep; 29(5):637-45. PubMed ID: 19562472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A high number of PD-L1
    Ando K; Hamada K; Shida M; Ohkuma R; Kubota Y; Horiike A; Matsui H; Ishiguro T; Hirasawa Y; Ariizumi H; Watanabe M; Onoue R; Tsurutani J; Yoshimura K; Tsunoda T; Kobayashi S; Wada S
    Cancer Immunol Immunother; 2021 Feb; 70(2):337-348. PubMed ID: 32757055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.
    Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL
    J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LIGHT (TNFSF14) Costimulation Enhances Myeloid Cell Activation and Antitumor Immunity in the Setting of PD-1/PD-L1 and TIGIT Checkpoint Blockade.
    Yoo KJ; Johannes K; González LE; Patel A; Shuptrine CW; Opheim Z; Lenz K; Campbell K; Nguyen TA; Miriyala J; Smith C; McGuire A; Tsai YH; Rangwala F; de Silva S; Schreiber TH; Fromm G
    J Immunol; 2022 Aug; 209(3):510-525. PubMed ID: 35817517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-classical monocytes predict progression of carotid artery bifurcation intima-media thickness in HIV-infected individuals on stable antiretroviral therapy.
    Chow DC; Kagihara JM; Zhang G; Souza SA; Hodis HN; Li Y; Mitchell BI; Nakamoto BK; Kallianpur KJ; Keating SM; Norris PJ; Kohorn LB; Ndhlovu LC; Shikuma CM
    HIV Clin Trials; 2016 May; 17(3):114-22. PubMed ID: 27125366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant Human Interleukin-15 and Anti-PD-L1 Combination Therapy Expands a CXCR3+PD1-/low CD8 T-Cell Subset in Simian Immunodeficiency Virus-Infected Rhesus Macaques.
    Chen P; Chen H; Moussa M; Cheng J; Li T; Qin J; Lifson JD; Sneller MC; Krymskaya L; Godin S; Lane HC; Catalfamo M
    J Infect Dis; 2020 Feb; 221(4):523-533. PubMed ID: 31562760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral blood lymphocytes differentiation patterns in responses / outcomes to immune checkpoint blockade therapies in non-small cell lung cancer: a retrospective study.
    Du X; Wen S; Shi R; Xia J; Wang R; Zhang Y; Pan B; Wu X; Zhu W; Feng J; Wang X; Shen B
    BMC Cancer; 2023 Jan; 23(1):83. PubMed ID: 36698098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune checkpoint expression on HIV-specific CD4+ T cells and response to their blockade are dependent on lineage and function.
    Brunet-Ratnasingham E; Morou A; Dubé M; Niessl J; Baxter AE; Tastet O; Brassard N; Ortega-Delgado G; Charlebois R; Freeman GJ; Tremblay C; Routy JP; Kaufmann DE
    EBioMedicine; 2022 Oct; 84():104254. PubMed ID: 36150362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S100A9
    Tu X; Chen L; Zheng Y; Mu C; Zhang Z; Wang F; Ren Y; Duan Y; Zhang H; Tong Z; Liu L; Sun X; Zhao P; Wang L; Feng X; Fang W; Liu X
    J Exp Clin Cancer Res; 2024 Mar; 43(1):72. PubMed ID: 38454445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.